Liver Disease
Latest News
Diet low in free sugars shows promise for adolescent NAFLD
Preliminary findings support potential of modified diet to improve hepatic steatosis in teens.
News
FDA approves cabozantinib for previously treated HCC
Approval was based on improvement in overall survival versus placebo in the phase 3 CELESTIAL trial.
From the Journals
Low-normal thyroid function tied to advanced fibrosis
In all, 5.9% of adults with low-normal thyroid function had advanced liver fibrosis, compared with 2.8% of individuals with strict-normal thyroid...
Conference Coverage
Does reduced degradation of insulin by the liver cause type 2 diabetes?
LOS ANGELES – Hepatic insulin clearance is significantly lower in African Americans, compared with European Americans, a difference that may...
From the Journals
Postdiagnosis statin use lowers mortality rate for patients with HCC
Statin use after a diagnosis of hepatocellular carcinoma was associated with a reduced risk of all-cause and cancer-specific mortality.
Practice Management Toolbox
Patient-reported outcomes for patients with chronic liver disease
This commentary focuses on reviewing the assessment and interpretation of PROs in CLD and why they are important in clinical practice.
From the Journals
Biomarker algorithm may offer noninvasive look at liver fibrosis
Algorithm distinguished NAFLD patients with advanced liver fibrosis from those with mild to moderate fibrosis.
From the Journals
HCC screening linked with improved tumor detection
Screening patients with cirrhosis for hepatocellular carcinoma is an underutilized early cancer–detection technique.
Conference Coverage
Hepatitis C debrief: Therapy has matured, access issues remain
Hepatitis C virus treatments are now broadly available, but challenges remain in getting the treatments to those who need them.
Conference Coverage
Early treatment with direct-acting antivirals linked to reduced medical costs in noncirrhotic HCV